Go back to Resource Center
The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results
14/10/2005
Conference Paper
Authors:
Aiello, L.P.;
Vignati, L.;
Sheetz, M.J.;
Zhi, X.;
Girach, A.;
Davis, M.D.;
Milton, R.C.;
Group, T.P.K.C.D.R.S.2 S.
Secondary:
American Academy of Ophthalmology
Location: Chicago, IL
URL:
http://www.aao.org/meetings/annual_meeting/program/past-archive.cfm
